205 related articles for article (PubMed ID: 2663144)
1. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
[TBL] [Abstract][Full Text] [Related]
2. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.
Shpall EJ; Bast RC; Joines WT; Jones RB; Anderson I; Johnston C; Eggleston S; Tepperberg M; Edwards S; Peters WP
Bone Marrow Transplant; 1991 Feb; 7(2):145-51. PubMed ID: 2049558
[TBL] [Abstract][Full Text] [Related]
3. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres.
O'Briant KC; Shpall EJ; Houston LL; Peters WP; Bast RC
Cancer; 1991 Sep; 68(6):1272-8. PubMed ID: 1873781
[TBL] [Abstract][Full Text] [Related]
4. Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement.
Haleem A; Kurtzberg J; Olsen GA; Rhinehardt-Clark A; Leslie DS; Ray L; Smith CA; Peters WP; Haynes BF; Bast RC
Cancer Res; 1987 Sep; 47(17):4608-12. PubMed ID: 3113721
[TBL] [Abstract][Full Text] [Related]
5. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
[TBL] [Abstract][Full Text] [Related]
6. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
7. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S
Cancer Res; 1987 Feb; 47(3):846-51. PubMed ID: 3492268
[TBL] [Abstract][Full Text] [Related]
8. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
Bast RC; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J
Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224
[TBL] [Abstract][Full Text] [Related]
9. Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads.
Vredenburgh JJ; Simpson W; Memoli VA; Ball ED
Cancer Res; 1991 May; 51(9):2451-5. PubMed ID: 1673088
[TBL] [Abstract][Full Text] [Related]
10. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
Montgomery RB; Kurtzberg J; Rhinehardt-Clark A; Haleen A; Ramakrishnan S; Olsen GA; Peters WP; Smith CA; Haynes BF; Houston LL
Bone Marrow Transplant; 1990 Jun; 5(6):395-402. PubMed ID: 2369680
[TBL] [Abstract][Full Text] [Related]
11. Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads.
Elias AD; Pap SA; Bernal SD
Prog Clin Biol Res; 1990; 333():263-75. PubMed ID: 2155434
[TBL] [Abstract][Full Text] [Related]
12. Purging breast cancer cells in preparation for autologous bone marrow transplantation.
Morecki S; Pavlotzky F; Margel S; Slavin S
Bone Marrow Transplant; 1987 Apr; 1(4):357-63. PubMed ID: 3332143
[TBL] [Abstract][Full Text] [Related]
13. Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrow.
Morecki S; Margel S; Slavin S
Cancer Res; 1988 Aug; 48(16):4573-7. PubMed ID: 3396008
[TBL] [Abstract][Full Text] [Related]
14. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles.
Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757
[TBL] [Abstract][Full Text] [Related]
15. Elimination of malignant tumor cells from human bone marrow using monoclonal antibodies and immunomagnetic beads.
Wang SY; Makl KL; Chen LY; Tzeng CH; Hu CP; Chang C
Anticancer Res; 1993; 13(6A):2281-5. PubMed ID: 8297147
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer.
Coombes RC; Buckman R; Forrester JA; Shepherd V; O'Hare MJ; Vincent M; Powles TJ; Neville AM
Cancer Res; 1986 Aug; 46(8):4217-20. PubMed ID: 3524802
[TBL] [Abstract][Full Text] [Related]
17. [Quantitative detection and elimination of neuroblastoma cells in vitro. Comparative study of the efficacy of an immunomagnetic method and lymphokine-activated killer cells].
Kästli M; Aapro M; Blaser K; Jeannet M; Irlé C
Schweiz Med Wochenschr; 1987 Nov; 117(46):1832-4. PubMed ID: 3321426
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow.
Myklebust AT; Godal A; Juell S; Pharo A; Fodstad O
Cancer Res; 1994 Jan; 54(1):209-14. PubMed ID: 7505198
[TBL] [Abstract][Full Text] [Related]
19. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M
Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989
[No Abstract] [Full Text] [Related]
20. Elimination of malignant clonogenic cells from human bone marrow using multiple myeloid cell-specific monoclonal antibodies and complement.
Hu ZB; Yu ZF; Qiao CN; Ma WL
Chin Med J (Engl); 1991 Aug; 104(8):664-8. PubMed ID: 1914634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
